Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Promoting mental health and wellbeing in schools: examining Mindfulness, Relaxation and Strategies for Safety and Wellbeing in English primary and secondary schools: study protocol for a multi-school, cluster randomised controlled trial (INSPIRE).

Hayes D, Moore A, Stapley E, Humphrey N, Mansfield R, Santos J, Ashworth E, Patalay P, Bonin EM, Moltrecht B, Boehnke JR, Deighton J.

Trials. 2019 Nov 21;20(1):640. doi: 10.1186/s13063-019-3762-0.

2.

School-based intervention study examining approaches for well-being and mental health literacy of pupils in Year 9 in England: study protocol for a multischool, parallel group cluster randomised controlled trial (AWARE).

Hayes D, Moore A, Stapley E, Humphrey N, Mansfield R, Santos J, Ashworth E, Patalay P, Bonin E, Boehnke JR, Deighton J.

BMJ Open. 2019 Sep 3;9(8):e029044. doi: 10.1136/bmjopen-2019-029044.

3.

Assessing risks to paediatric patients: conversation analysis of situation awareness in huddle meetings in England.

Hayes J, Lachman P, Edbrooke-Childs J, Stapley E, Wolpert M, Deighton J.

BMJ Open. 2019 May 27;9(5):e023437. doi: 10.1136/bmjopen-2018-023437.

4.

Facing Shadows: working with young people to coproduce a short film about depression.

Dunn V, O'Keeffe S, Stapley E, Midgley N.

Res Involv Engagem. 2018 Nov 27;4:46. doi: 10.1186/s40900-018-0126-y. eCollection 2018.

5.

Factors to consider in the introduction of huddles on clinical wards: perceptions of staff on the SAFE programme.

Stapley E, Sharples E, Lachman P, Lakhanpaul M, Wolpert M, Deighton J.

Int J Qual Health Care. 2018 Feb 1;30(1):44-49. doi: 10.1093/intqhc/mzx162.

6.

Development of the Huddle Observation Tool for structured case management discussions to improve situation awareness on inpatient clinical wards.

Edbrooke-Childs J, Hayes J, Sharples E, Gondek D, Stapley E, Sevdalis N, Lachman P, Deighton J.

BMJ Qual Saf. 2018 May;27(5):365-372. doi: 10.1136/bmjqs-2017-006513. Epub 2017 Sep 19.

7.

The Journey Through and Beyond Mental Health Services in the United Kingdom: A Typology of Parents' Ways of Managing the Crisis of Their Teenage Child's Depression.

Stapley E, Target M, Midgley N.

J Clin Psychol. 2017 Oct;73(10):1429-1441. doi: 10.1002/jclp.22446. Epub 2017 Jan 24.

PMID:
28117889
8.

Realistic evaluation of Situation Awareness for Everyone (SAFE) on paediatric wards: study protocol.

Deighton J, Edbrooke-Childs J, Stapley E, Sevdalis N, Hayes J, Gondek D, Sharples E, Lachman P.

BMJ Open. 2016 Dec 30;6(12):e014014. doi: 10.1136/bmjopen-2016-014014. Erratum in: BMJ Open. 2017 Feb 22;7(2):e014014corr1.

9.

"Did I bring it on myself?" An exploratory study of the beliefs that adolescents referred to mental health services have about the causes of their depression.

Midgley N, Parkinson S, Holmes J, Stapley E, Eatough V, Target M.

Eur Child Adolesc Psychiatry. 2017 Jan;26(1):25-34. doi: 10.1007/s00787-016-0868-8. Epub 2016 May 20.

10.

Beyond a diagnosis: The experience of depression among clinically-referred adolescents.

Midgley N, Parkinson S, Holmes J, Stapley E, Eatough V, Target M.

J Adolesc. 2015 Oct;44:269-79. doi: 10.1016/j.adolescence.2015.08.007. Epub 2015 Aug 30.

PMID:
26325067
11.

"Just like talking to someone about like shit in your life and stuff, and they help you": Hopes and expectations for therapy among depressed adolescents.

Midgley N, Holmes J, Parkinson S, Stapley E, Eatough V, Target M.

Psychother Res. 2016;26(1):11-21. doi: 10.1080/10503307.2014.973922. Epub 2014 Nov 5.

PMID:
25372575
12.

The discovery of cell wall active antibacterial antibiotics.

Gadebusch HH, Stapley EO, Zimmerman SB.

Crit Rev Biotechnol. 1992;12(3):225-43. Review. No abstract available.

PMID:
1633621
13.

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.

Chang RS, Lotti VJ, Monaghan RL, Birnbaum J, Stapley EO, Goetz MA, Albers-Schönberg G, Patchett AA, Liesch JM, Hensens OD, et al.

Science. 1985 Oct 11;230(4722):177-9.

PMID:
2994227
14.

Use of a computer to group actinomycetes for studies on the ecology of soil microorganisms.

Keast D, Rowe P, Sanfelieu L, Shannahan J, Bowra B, Skates S, Stapley EO, Woodruff HB.

Appl Environ Microbiol. 1984 Oct;48(4):791-6.

15.

Discovery, production and purification of the Na+, K+ activated ATPase inhibitor, L-681,110 from the fermentation broth of Streptomyces sp. MA-5038.

Huang L, Albers-Schonberg G, Monaghan RL, Jakubas K, Pong SS, Hensens OD, Burg RW, Ostlind DA, Conroy J, Stapley EO.

J Antibiot (Tokyo). 1984 Sep;37(9):970-5.

16.

Studies on the ecology of West Australian actinomycetes: Factors which influence the diversity and types of actionomycetes in Australian soils.

Keast D, Rowe P, Bowra B, Sanfelieu L, Stapley EO, Woodruff HB.

Microb Ecol. 1984 Jun;10(2):123-36. doi: 10.1007/BF02011420.

PMID:
24221093
17.

GELRITE as an Agar Substitute in Bacteriological Media.

Shungu D, Valiant M, Tutlane V, Weinberg E, Weissberger B, Koupal L, Gadebusch H, Stapley E.

Appl Environ Microbiol. 1983 Oct;46(4):840-5.

18.

Ivermectin: a potent new antiparasitic agent.

Campbell WC, Fisher MH, Stapley EO, Albers-Schönberg G, Jacob TA.

Science. 1983 Aug 26;221(4613):823-8.

PMID:
6308762
19.
20.

Epithienamycins. II. Isolation and structure assignment.

Cassidy PJ, Albers-Schonberg G, Goegelman RT, Miller T, Arison B, Stapley EO, Birnbaum J.

J Antibiot (Tokyo). 1981 Jun;34(6):637-48.

21.

Epithienamycins-novel beta-lactams related to thienamycin. I. Production and antibacterial activity.

Stapley EO, Cassidy PJ, Tunac J, Monaghan RL, Jackson M, Hernandez S, Zimmerman SB, Mata JM, Currie SA, Daoust D, Hendlin D.

J Antibiot (Tokyo). 1981 Jun;34(6):628-36.

22.

An animal model for assessing pain-on-injection of antibiotics.

Celozzi E, Lotti VJ, Stapley EO, Miller AK.

J Pharmacol Methods. 1980 Dec;4(4):285-9.

PMID:
7206736
23.

In vivo inoculum effect and resistance selection with cefamandole and cefoxitin against Enterobacter cloacae in mice.

Miller AK, Celozzi E, Pelak BA, Birnbaum J, Stapley EO.

J Antimicrob Chemother. 1980 Nov;6(6):804-6. No abstract available.

PMID:
7002900
24.

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, Springer J.

Proc Natl Acad Sci U S A. 1980 Jul;77(7):3957-61.

25.

Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.

Miller AK, Celozzi E, Pelak BA, Birnbaum J, Stapley EO.

J Antimicrob Chemother. 1979 Sep;5(5):569-79.

PMID:
315403
26.

Heneicomycin, a new antibiotic (A21A): fermentation, isolation, and antibacterial spectrum.

Zimmerman SB, Chalmers JH Jr, Dewey RS, Stapley EO, Hernandez S.

J Antibiot (Tokyo). 1979 Jun;32(6):665-6. No abstract available.

27.

Avermectins, new family of potent anthelmintic agents: producing organism and fermentation.

Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong YL, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, Omura S.

Antimicrob Agents Chemother. 1979 Mar;15(3):361-7.

28.

Evolution of an antibiotic screening programme. A tribute to Justo Martinez Mata.

Woodruff HB, Hernandez S, Stapley EO.

Hindustan Antibiot Bull. 1979 Feb;21(3):71-84. Review. No abstract available.

PMID:
396280
29.

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Kahan JS, Kahan FM, Goegelman R, Currie SA, Jackson M, Stapley EO, Miller TW, Miller AK, Hendlin D, Mochales S, Hernandez S, Woodruff HB, Birnbaum J.

J Antibiot (Tokyo). 1979 Jan;32(1):1-12.

30.

Cefoxitin and cephamycins: microbiological studies.

Stapley EO, Birnbaum J, Miller AK, Wallick H, Hendlin D, Woodruff HB.

Rev Infect Dis. 1979 Jan-Feb;1(1):73-89. Review.

PMID:
400941
31.

[Cefoxitin, a new semi-synthetic cephamycin (author's transl)].

Stapley EO, Birnbaum J.

Sem Hop. 1978 Oct 8-15;54(29-32):975-81. French.

PMID:
216093
32.

Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.

Birnbaum J, Stapley EO, Miller AK, Wallick H, Hendlin D, Woodruff HB.

J Antimicrob Chemother. 1978 Jul;4(B):15-32. Review. No abstract available.

PMID:
357379
33.

Fosfomycin: Laboratory studies.

Woodruff HB, Mata JM, Hernández S, Mochales S, Rodríguez A, Stapley EO, Wallick H, Miller AK, Hendlin D.

Chemotherapy. 1977;23 Suppl 1:1-22.

PMID:
583866
34.

Fosfomycin treatment of Haemophilus influenzae infection in mice.

Miller AK, Kong YL, Stapley EO.

Chemotherapy. 1977;23 Suppl 1:75-81.

PMID:
299838
35.

Relative morphological effects induced by cefoxitin and other beta-lactam antibiotics in vitro.

Zimmerman SB, Stapley EO.

Antimicrob Agents Chemother. 1976 Feb;9(2):318-26.

36.

Observations on the mode of action of cefoxitin.

Onishi HR, Zimmerman SB, Stapley EO.

Ann N Y Acad Sci. 1974 May 10;235(0):406-25. No abstract available.

PMID:
4604846
37.

Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation.

Miller AK, Celozzi E, Kong Y, Pelak BA, Hendlin D, Stapley EO.

Antimicrob Agents Chemother. 1974 Jan;5(1):33-7.

38.

Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Onishi HR, Daoust DR, Zimmerman SB, Hendlin D, Stapley EO.

Antimicrob Agents Chemother. 1974 Jan;5(1):38-48.

39.

Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n.

Stapley EO, Jackson M, Hernandez S, Zimmerman SB, Currie SA, Mochales S, Mata JM, Woodruff HB, Hendlin D.

Antimicrob Agents Chemother. 1972 Sep;2(3):122-31.

40.

Cephamycins, a new family of beta-lactam antibiotics: antibacterial activity and resistance to beta-lactamase degradation.

Daoust DR, Onishi HR, Wallick H, Hendlin D, Stapley EO.

Antimicrob Agents Chemother. 1973 Feb;3(2):254-61.

41.

Cephamycins, a new family of beta-lactam antibiotics. IV. In vivo studies.

Miller AK, Celozzi E, Kong Y, Pelak BA, Kropp H, Stapley EO, Hendlin D.

Antimicrob Agents Chemother. 1972 Oct;2(4):287-90.

42.

Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studies.

Miller AK, Celozzi E, Pelak BA, Stapley EO, Hendlin D.

Antimicrob Agents Chemother. 1972 Oct;2(4):281-6.

43.

Azirinomycin. I. Microbial production and biological characteristics.

Stapley EO, Hendlin D, Jackson M, Miller AK, Hernandez S, Mata JM.

J Antibiot (Tokyo). 1971 Jan;24(1):42-7. No abstract available.

44.

Phosphonomycin, a new antibiotic produced by strains of streptomyces.

Hendlin D, Stapley EO, Jackson M, Wallick H, Miller AK, Wolf FJ, Miller TW, Chaiet L, Kahan FM, Foltz EL, Woodruff HB, Mata JM, Hernandez S, Mochales S.

Science. 1969 Oct 3;166(3901):122-3.

PMID:
5809587
45.

Antibiotic MSD-819. Preparation and properties of biologically active derivatives.

Miller TW, Miller AK, Wolf FJ, Stapley EO, Hendlin D.

J Antibiot (Tokyo). 1969 Jul;22(7):293-6. No abstract available.

46.

Phosphonomycin. IV. Susceptibility testing method and survey.

Zimmerman SB, Stapley EO, Wallick H, Baldwin R.

Antimicrob Agents Chemother (Bethesda). 1969;9:303-9. No abstract available.

PMID:
5396505
47.

Phosphonomycin. II. Fermentation studies.

Jackson M, Stapley EO.

Antimicrob Agents Chemother (Bethesda). 1969;9:291-6. No abstract available.

PMID:
5396504
48.

Phosphonomycin. I. Discovery and in vitro biological characterization.

Stapley EO, Hendlin D, Mata JM, Jackson M, Wallick H, Hernandez S, Mochales S, Currie SA, Miller RM.

Antimicrob Agents Chemother (Bethesda). 1969;9:284-90. No abstract available.

PMID:
5396502
49.

Production of the antibiotic D-4-amino-3-isoxazolidone by bacteria.

Stapley EO, Miller TW, Jackson M.

Antimicrob Agents Chemother (Bethesda). 1968;8:268-73. No abstract available.

PMID:
5735372
50.

Antibiotic MSD-819. I. Microbial production and biological characteristics.

Stapley EO, Hendlin D, Mata JM, Hernandez S, Miller AK, Jackson M, Wallick H.

Antimicrob Agents Chemother (Bethesda). 1968;8:249-54. No abstract available.

PMID:
5735368

Supplemental Content

Loading ...
Support Center